Search results
Results from the WOW.Com Content Network
Raloxifene is a selective estrogen receptor modulator (SERM) and therefore a mixed agonist–antagonist of the estrogen receptor (ER). [6] It has estrogenic effects in bone and antiestrogenic effects in the breasts and uterus. [6] Raloxifene was approved for medical use in the United States in 1997. [6] It is available as a generic medication.
Raloxifene belongs to the second-generation benzothiophene SERM drugs. It has a high affinity for the ER with potent antiestrogenic activity and tissue-specific effects distinct from estradiol. [19] Raloxifene is an ER agonist in bone and the cardiovascular system, but in breast tissue and the endometrium it acts as an ER antagonist.
One of the largest breast cancer prevention studies ever, [2] it included 22,000 women in 400 medical centers in the United States and Canada. [3] [4] [5]The study concluded that raloxifene caused fewer side-effects and less endometrial cancer than tamoxifen.
Raloxifene chemical structure. Raloxifene is a known chemical compound used to treat osteoporosis. As a result of drug repositioning experiments, the E4C project identified raloxifene as a possible candidate to treat early-stage COVID-19 patients, [6] [5] aiming to prevent clinical progression. [25]
She is only 5 or 6 years old, a very active German Rottweiler and Black Mouth Cur mix, and about 80 pounds." It is hard to suggest a treatment without knowing the cause of the cancer.
Editor’s Note: Help is available if you or someone you know is struggling with suicidal thoughts or mental health matters. In the US: Call or text 988, the Suicide & Crisis Lifeline.
The antiestrogen withdrawal response is a paradoxical improvement in breast cancer caused by discontinuation of antiestrogen therapy for breast cancer. [1] [2] [3] [4 ...
The vast majority of people whose call records have been stolen by Chinese hackers have not been notified, according to industry sources, and there is no indication that most affected people will ...